Johns) 747765 (Springer Berlin Heidelberg, 1975)
GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone to slow digestion, reduce appetite, and regulate blood sugar
After treatment , common effects include bruising at injection sites (10-15% of clients), temporary fatigue, and increased urination
MUFAs, such as oleic acid, are acylated by ACSL3 and incorporated into cellular phospholipids
Following laboratory safety standards helps reduce the risk of accidental exposure, contamination, and handling errors
That means just under the skin, not into muscle